WebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, … WebCancerTYPE ID Hologic
Hologic, Inc. - Hologic Completes Acquisition of …
WebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing … WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.Biotheranostics develops and markets two highly differentiated molecular … how many calories in tassimo hot chocolate
Breast Cancer Index
WebJan 5, 2024 · On January 5, 2024, Hologic acquired life science company Biotheranostics for 230M USD Acquisition Highlights. This is Hologic’s 2nd transaction in the Life Science sector. This is Hologic’s 7th largest (disclosed) transaction. This is Hologic’s 15th transaction in the United States. This is Hologic’s 4th transaction in California. http://www.biotheranostics.com/ WebHologic announced a $230 million deal in which it will acquire Biotheranostics, a private company that provides molecular diagnostic tests for breast and metastatic cancers. Through the purchase, Hologic aims to enhance its current work in the field of oncology with more personalized treatment and better outcomes for women. high rise work pants for women